These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 26669245)

  • 21. Heteromers Formed by GPR55 and Either Cannabinoid CB
    Menéndez-Pérez C; Rivas-Santisteban R; Del Valle E; Tolivia J; Navarro A; Franco R; Martínez-Pinilla E
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel cannabinoid receptors.
    Brown AJ
    Br J Pharmacol; 2007 Nov; 152(5):567-75. PubMed ID: 17906678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
    Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
    J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potential role for GPR55 in gastrointestinal functions.
    Schicho R; Storr M
    Curr Opin Pharmacol; 2012 Dec; 12(6):653-8. PubMed ID: 23063456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.
    Galiazzo G; Giancola F; Stanzani A; Fracassi F; Bernardini C; Forni M; Pietra M; Chiocchetti R
    Histochem Cell Biol; 2018 Aug; 150(2):187-205. PubMed ID: 29882158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice.
    Ross GR; Lichtman A; Dewey WL; Akbarali HI
    Pharmacology; 2012; 90(1-2):55-65. PubMed ID: 22759743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.
    Johns DG; Behm DJ; Walker DJ; Ao Z; Shapland EM; Daniels DA; Riddick M; Dowell S; Staton PC; Green P; Shabon U; Bao W; Aiyar N; Yue TL; Brown AJ; Morrison AD; Douglas SA
    Br J Pharmacol; 2007 Nov; 152(5):825-31. PubMed ID: 17704827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid-sensitive receptors in cardiac physiology and ischaemia.
    Puhl SL
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118462. PubMed ID: 30890410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPR55 and the vascular receptors for cannabinoids.
    Hiley CR; Kaup SS
    Br J Pharmacol; 2007 Nov; 152(5):559-61. PubMed ID: 17704825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Emerging Role of the Cannabinoid Receptor Family in Peripheral and Neuro-immune Interactions.
    Haugh O; Penman J; Irving AJ; Campbell VA
    Curr Drug Targets; 2016; 17(16):1834-1840. PubMed ID: 26758668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Off-target cannabinoid effects mediated by GPR55.
    Henstridge CM
    Pharmacology; 2012; 89(3-4):179-87. PubMed ID: 22433274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances Towards The Discovery of GPR55 Ligands.
    Morales P; Jagerovic N
    Curr Med Chem; 2016; 23(20):2087-100. PubMed ID: 27109575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.
    Henstridge CM; Balenga NA; Kargl J; Andradas C; Brown AJ; Irving A; Sanchez C; Waldhoer M
    Mol Endocrinol; 2011 Nov; 25(11):1835-48. PubMed ID: 21964594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.
    Hasenoehrl C; Feuersinger D; Sturm EM; Bärnthaler T; Heitzer E; Graf R; Grill M; Pichler M; Beck S; Butcher L; Thomas D; Ferreirós N; Schuligoi R; Schweiger C; Haybaeck J; Schicho R
    Int J Cancer; 2018 Jan; 142(1):121-132. PubMed ID: 28875496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enigmatic pharmacology of GPR55.
    Ross RA
    Trends Pharmacol Sci; 2009 Mar; 30(3):156-63. PubMed ID: 19233486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPR55: a new member of the cannabinoid receptor clan?
    Pertwee RG
    Br J Pharmacol; 2007 Dec; 152(7):984-6. PubMed ID: 17876300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents.
    Lin XH; Yuece B; Li YY; Feng YJ; Feng JY; Yu LY; Li K; Li YN; Storr M
    Neurogastroenterol Motil; 2011 Sep; 23(9):862-e342. PubMed ID: 21726355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Madrigal KE; Hurst DP; Sharir H; Lynch DL; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak L; Abood ME; Reggio PH
    Biochemistry; 2011 Jun; 50(25):5633-47. PubMed ID: 21534610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.
    Moreno E; Andradas C; Medrano M; Caffarel MM; Pérez-Gómez E; Blasco-Benito S; Gómez-Cañas M; Pazos MR; Irving AJ; Lluís C; Canela EI; Fernández-Ruiz J; Guzmán M; McCormick PJ; Sánchez C
    J Biol Chem; 2014 Aug; 289(32):21960-72. PubMed ID: 24942731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.